The global Artificial Intelligence in Biotechnology market size was valued at US$ 309 million in 2023 and is forecast to a readjusted size of USD 2020 million by 2030 with a CAGR of 30.3% during review period.
Artificial Intelligence (AI) in biotechnology refers to the integration of AI technologies, such as machine learning, data analytics, and computer vision, into biotechnological processes. It is used to optimize genetic engineering, enhance drug development, improve bio-manufacturing efficiency, and accelerate innovations in fields like agriculture, healthcare, and environmental science. AI in biotechnology enables the analysis of large datasets to uncover patterns, predict outcomes, and develop solutions faster and more accurately.
This report is a detailed and comprehensive analysis for global Artificial Intelligence in Biotechnology market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Artificial Intelligence in Biotechnology market size and forecasts, in consumption value ($ Million), 2019-2030
Global Artificial Intelligence in Biotechnology market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Artificial Intelligence in Biotechnology market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Artificial Intelligence in Biotechnology market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Artificial Intelligence in Biotechnology
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Artificial Intelligence in Biotechnology market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca, Thales Group, IBM Corp., ForeSee Medical, Atomwise, Cloud Pharmaceuticals, GNS Healthcare, Microsoft Corporation, Novartis AG, NVIDIA Corporation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 segmentation
Artificial Intelligence in Biotechnology market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Hardware
Software
麻豆原创 segment by Application
Healthcare and Medicine
Agriculture
Industrial Biotechnology
Environmental Biotechnology
Food and Beverage Industry
Others
麻豆原创 segment by players, this report covers
AstraZeneca
Thales Group
IBM Corp.
ForeSee Medical
Atomwise
Cloud Pharmaceuticals
GNS Healthcare
Microsoft Corporation
Novartis AG
NVIDIA Corporation
Pfizer
Recursion Pharmaceuticals
XtalPi Inc
Aidoc
AliveCor
GE Healthcare
Imagen Technologies
Vuno Inc.
IDx Technologies Inc.
Siemens Healthcare GmbH
Neural Analytics
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Artificial Intelligence in Biotechnology product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Artificial Intelligence in Biotechnology, with revenue, gross margin, and global market share of Artificial Intelligence in Biotechnology from 2019 to 2024.
Chapter 3, the Artificial Intelligence in Biotechnology competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Artificial Intelligence in Biotechnology market forecast, by regions, by Type and by Application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Artificial Intelligence in Biotechnology.
Chapter 13, to describe Artificial Intelligence in Biotechnology research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Artificial Intelligence in Biotechnology by Type
1.3.1 Overview: Global Artificial Intelligence in Biotechnology 麻豆原创 Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Artificial Intelligence in Biotechnology Consumption Value 麻豆原创 Share by Type in 2023
1.3.3 Hardware
1.3.4 Software
1.4 Global Artificial Intelligence in Biotechnology 麻豆原创 by Application
1.4.1 Overview: Global Artificial Intelligence in Biotechnology 麻豆原创 Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Healthcare and Medicine
1.4.3 Agriculture
1.4.4 Industrial Biotechnology
1.4.5 Environmental Biotechnology
1.4.6 Food and Beverage Industry
1.4.7 Others
1.5 Global Artificial Intelligence in Biotechnology 麻豆原创 Size & Forecast
1.6 Global Artificial Intelligence in Biotechnology 麻豆原创 Size and Forecast by Region
1.6.1 Global Artificial Intelligence in Biotechnology 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Artificial Intelligence in Biotechnology 麻豆原创 Size by Region, (2019-2030)
1.6.3 North America Artificial Intelligence in Biotechnology 麻豆原创 Size and Prospect (2019-2030)
1.6.4 Europe Artificial Intelligence in Biotechnology 麻豆原创 Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Artificial Intelligence in Biotechnology 麻豆原创 Size and Prospect (2019-2030)
1.6.6 South America Artificial Intelligence in Biotechnology 麻豆原创 Size and Prospect (2019-2030)
1.6.7 Middle East & Africa Artificial Intelligence in Biotechnology 麻豆原创 Size and Prospect (2019-2030)
2 Company Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Artificial Intelligence in Biotechnology Product and Solutions
2.1.4 AstraZeneca Artificial Intelligence in Biotechnology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 AstraZeneca Recent Developments and Future Plans
2.2 Thales Group
2.2.1 Thales Group Details
2.2.2 Thales Group Major Business
2.2.3 Thales Group Artificial Intelligence in Biotechnology Product and Solutions
2.2.4 Thales Group Artificial Intelligence in Biotechnology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Thales Group Recent Developments and Future Plans
2.3 IBM Corp.
2.3.1 IBM Corp. Details
2.3.2 IBM Corp. Major Business
2.3.3 IBM Corp. Artificial Intelligence in Biotechnology Product and Solutions
2.3.4 IBM Corp. Artificial Intelligence in Biotechnology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 IBM Corp. Recent Developments and Future Plans
2.4 ForeSee Medical
2.4.1 ForeSee Medical Details
2.4.2 ForeSee Medical Major Business
2.4.3 ForeSee Medical Artificial Intelligence in Biotechnology Product and Solutions
2.4.4 ForeSee Medical Artificial Intelligence in Biotechnology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 ForeSee Medical Recent Developments and Future Plans
2.5 Atomwise
2.5.1 Atomwise Details
2.5.2 Atomwise Major Business
2.5.3 Atomwise Artificial Intelligence in Biotechnology Product and Solutions
2.5.4 Atomwise Artificial Intelligence in Biotechnology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Atomwise Recent Developments and Future Plans
2.6 Cloud Pharmaceuticals
2.6.1 Cloud Pharmaceuticals Details
2.6.2 Cloud Pharmaceuticals Major Business
2.6.3 Cloud Pharmaceuticals Artificial Intelligence in Biotechnology Product and Solutions
2.6.4 Cloud Pharmaceuticals Artificial Intelligence in Biotechnology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Cloud Pharmaceuticals Recent Developments and Future Plans
2.7 GNS Healthcare
2.7.1 GNS Healthcare Details
2.7.2 GNS Healthcare Major Business
2.7.3 GNS Healthcare Artificial Intelligence in Biotechnology Product and Solutions
2.7.4 GNS Healthcare Artificial Intelligence in Biotechnology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 GNS Healthcare Recent Developments and Future Plans
2.8 Microsoft Corporation
2.8.1 Microsoft Corporation Details
2.8.2 Microsoft Corporation Major Business
2.8.3 Microsoft Corporation Artificial Intelligence in Biotechnology Product and Solutions
2.8.4 Microsoft Corporation Artificial Intelligence in Biotechnology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 Microsoft Corporation Recent Developments and Future Plans
2.9 Novartis AG
2.9.1 Novartis AG Details
2.9.2 Novartis AG Major Business
2.9.3 Novartis AG Artificial Intelligence in Biotechnology Product and Solutions
2.9.4 Novartis AG Artificial Intelligence in Biotechnology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 Novartis AG Recent Developments and Future Plans
2.10 NVIDIA Corporation
2.10.1 NVIDIA Corporation Details
2.10.2 NVIDIA Corporation Major Business
2.10.3 NVIDIA Corporation Artificial Intelligence in Biotechnology Product and Solutions
2.10.4 NVIDIA Corporation Artificial Intelligence in Biotechnology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 NVIDIA Corporation Recent Developments and Future Plans
2.11 Pfizer
2.11.1 Pfizer Details
2.11.2 Pfizer Major Business
2.11.3 Pfizer Artificial Intelligence in Biotechnology Product and Solutions
2.11.4 Pfizer Artificial Intelligence in Biotechnology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.11.5 Pfizer Recent Developments and Future Plans
2.12 Recursion Pharmaceuticals
2.12.1 Recursion Pharmaceuticals Details
2.12.2 Recursion Pharmaceuticals Major Business
2.12.3 Recursion Pharmaceuticals Artificial Intelligence in Biotechnology Product and Solutions
2.12.4 Recursion Pharmaceuticals Artificial Intelligence in Biotechnology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.12.5 Recursion Pharmaceuticals Recent Developments and Future Plans
2.13 XtalPi Inc
2.13.1 XtalPi Inc Details
2.13.2 XtalPi Inc Major Business
2.13.3 XtalPi Inc Artificial Intelligence in Biotechnology Product and Solutions
2.13.4 XtalPi Inc Artificial Intelligence in Biotechnology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.13.5 XtalPi Inc Recent Developments and Future Plans
2.14 Aidoc
2.14.1 Aidoc Details
2.14.2 Aidoc Major Business
2.14.3 Aidoc Artificial Intelligence in Biotechnology Product and Solutions
2.14.4 Aidoc Artificial Intelligence in Biotechnology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.14.5 Aidoc Recent Developments and Future Plans
2.15 AliveCor
2.15.1 AliveCor Details
2.15.2 AliveCor Major Business
2.15.3 AliveCor Artificial Intelligence in Biotechnology Product and Solutions
2.15.4 AliveCor Artificial Intelligence in Biotechnology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.15.5 AliveCor Recent Developments and Future Plans
2.16 GE Healthcare
2.16.1 GE Healthcare Details
2.16.2 GE Healthcare Major Business
2.16.3 GE Healthcare Artificial Intelligence in Biotechnology Product and Solutions
2.16.4 GE Healthcare Artificial Intelligence in Biotechnology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.16.5 GE Healthcare Recent Developments and Future Plans
2.17 Imagen Technologies
2.17.1 Imagen Technologies Details
2.17.2 Imagen Technologies Major Business
2.17.3 Imagen Technologies Artificial Intelligence in Biotechnology Product and Solutions
2.17.4 Imagen Technologies Artificial Intelligence in Biotechnology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.17.5 Imagen Technologies Recent Developments and Future Plans
2.18 Vuno Inc.
2.18.1 Vuno Inc. Details
2.18.2 Vuno Inc. Major Business
2.18.3 Vuno Inc. Artificial Intelligence in Biotechnology Product and Solutions
2.18.4 Vuno Inc. Artificial Intelligence in Biotechnology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.18.5 Vuno Inc. Recent Developments and Future Plans
2.19 IDx Technologies Inc.
2.19.1 IDx Technologies Inc. Details
2.19.2 IDx Technologies Inc. Major Business
2.19.3 IDx Technologies Inc. Artificial Intelligence in Biotechnology Product and Solutions
2.19.4 IDx Technologies Inc. Artificial Intelligence in Biotechnology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.19.5 IDx Technologies Inc. Recent Developments and Future Plans
2.20 Siemens Healthcare GmbH
2.20.1 Siemens Healthcare GmbH Details
2.20.2 Siemens Healthcare GmbH Major Business
2.20.3 Siemens Healthcare GmbH Artificial Intelligence in Biotechnology Product and Solutions
2.20.4 Siemens Healthcare GmbH Artificial Intelligence in Biotechnology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.20.5 Siemens Healthcare GmbH Recent Developments and Future Plans
2.21 Neural Analytics
2.21.1 Neural Analytics Details
2.21.2 Neural Analytics Major Business
2.21.3 Neural Analytics Artificial Intelligence in Biotechnology Product and Solutions
2.21.4 Neural Analytics Artificial Intelligence in Biotechnology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.21.5 Neural Analytics Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Artificial Intelligence in Biotechnology Revenue and Share by Players (2019-2024)
3.2 麻豆原创 Share Analysis (2023)
3.2.1 麻豆原创 Share of Artificial Intelligence in Biotechnology by Company Revenue
3.2.2 Top 3 Artificial Intelligence in Biotechnology Players 麻豆原创 Share in 2023
3.2.3 Top 6 Artificial Intelligence in Biotechnology Players 麻豆原创 Share in 2023
3.3 Artificial Intelligence in Biotechnology 麻豆原创: Overall Company Footprint Analysis
3.3.1 Artificial Intelligence in Biotechnology 麻豆原创: Region Footprint
3.3.2 Artificial Intelligence in Biotechnology 麻豆原创: Company Product Type Footprint
3.3.3 Artificial Intelligence in Biotechnology 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Artificial Intelligence in Biotechnology Consumption Value and 麻豆原创 Share by Type (2019-2024)
4.2 Global Artificial Intelligence in Biotechnology 麻豆原创 Forecast by Type (2025-2030)
5 麻豆原创 Size Segment by Application
5.1 Global Artificial Intelligence in Biotechnology Consumption Value 麻豆原创 Share by Application (2019-2024)
5.2 Global Artificial Intelligence in Biotechnology 麻豆原创 Forecast by Application (2025-2030)
6 North America
6.1 North America Artificial Intelligence in Biotechnology Consumption Value by Type (2019-2030)
6.2 North America Artificial Intelligence in Biotechnology 麻豆原创 Size by Application (2019-2030)
6.3 North America Artificial Intelligence in Biotechnology 麻豆原创 Size by Country
6.3.1 North America Artificial Intelligence in Biotechnology Consumption Value by Country (2019-2030)
6.3.2 United States Artificial Intelligence in Biotechnology 麻豆原创 Size and Forecast (2019-2030)
6.3.3 Canada Artificial Intelligence in Biotechnology 麻豆原创 Size and Forecast (2019-2030)
6.3.4 Mexico Artificial Intelligence in Biotechnology 麻豆原创 Size and Forecast (2019-2030)
7 Europe
7.1 Europe Artificial Intelligence in Biotechnology Consumption Value by Type (2019-2030)
7.2 Europe Artificial Intelligence in Biotechnology Consumption Value by Application (2019-2030)
7.3 Europe Artificial Intelligence in Biotechnology 麻豆原创 Size by Country
7.3.1 Europe Artificial Intelligence in Biotechnology Consumption Value by Country (2019-2030)
7.3.2 Germany Artificial Intelligence in Biotechnology 麻豆原创 Size and Forecast (2019-2030)
7.3.3 France Artificial Intelligence in Biotechnology 麻豆原创 Size and Forecast (2019-2030)
7.3.4 United Kingdom Artificial Intelligence in Biotechnology 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Russia Artificial Intelligence in Biotechnology 麻豆原创 Size and Forecast (2019-2030)
7.3.6 Italy Artificial Intelligence in Biotechnology 麻豆原创 Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Artificial Intelligence in Biotechnology Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Artificial Intelligence in Biotechnology Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Artificial Intelligence in Biotechnology 麻豆原创 Size by Region
8.3.1 Asia-Pacific Artificial Intelligence in Biotechnology Consumption Value by Region (2019-2030)
8.3.2 China Artificial Intelligence in Biotechnology 麻豆原创 Size and Forecast (2019-2030)
8.3.3 Japan Artificial Intelligence in Biotechnology 麻豆原创 Size and Forecast (2019-2030)
8.3.4 South Korea Artificial Intelligence in Biotechnology 麻豆原创 Size and Forecast (2019-2030)
8.3.5 India Artificial Intelligence in Biotechnology 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Southeast Asia Artificial Intelligence in Biotechnology 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Australia Artificial Intelligence in Biotechnology 麻豆原创 Size and Forecast (2019-2030)
9 South America
9.1 South America Artificial Intelligence in Biotechnology Consumption Value by Type (2019-2030)
9.2 South America Artificial Intelligence in Biotechnology Consumption Value by Application (2019-2030)
9.3 South America Artificial Intelligence in Biotechnology 麻豆原创 Size by Country
9.3.1 South America Artificial Intelligence in Biotechnology Consumption Value by Country (2019-2030)
9.3.2 Brazil Artificial Intelligence in Biotechnology 麻豆原创 Size and Forecast (2019-2030)
9.3.3 Argentina Artificial Intelligence in Biotechnology 麻豆原创 Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Artificial Intelligence in Biotechnology Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Artificial Intelligence in Biotechnology Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Artificial Intelligence in Biotechnology 麻豆原创 Size by Country
10.3.1 Middle East & Africa Artificial Intelligence in Biotechnology Consumption Value by Country (2019-2030)
10.3.2 Turkey Artificial Intelligence in Biotechnology 麻豆原创 Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Artificial Intelligence in Biotechnology 麻豆原创 Size and Forecast (2019-2030)
10.3.4 UAE Artificial Intelligence in Biotechnology 麻豆原创 Size and Forecast (2019-2030)
11 麻豆原创 Dynamics
11.1 Artificial Intelligence in Biotechnology 麻豆原创 Drivers
11.2 Artificial Intelligence in Biotechnology 麻豆原创 Restraints
11.3 Artificial Intelligence in Biotechnology Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Artificial Intelligence in Biotechnology Industry Chain
12.2 Artificial Intelligence in Biotechnology Upstream Analysis
12.3 Artificial Intelligence in Biotechnology Midstream Analysis
12.4 Artificial Intelligence in Biotechnology Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
AstraZeneca
Thales Group
IBM Corp.
ForeSee Medical
Atomwise
Cloud Pharmaceuticals
GNS Healthcare
Microsoft Corporation
Novartis AG
NVIDIA Corporation
Pfizer
Recursion Pharmaceuticals
XtalPi Inc
Aidoc
AliveCor
GE Healthcare
Imagen Technologies
Vuno Inc.
IDx Technologies Inc.
Siemens Healthcare GmbH
Neural Analytics
听
听
*If Applicable.